The hedge fund’s shares of CHS are valued at $17.36 million.
CHS’ stock price has declined 40.9 percent since the end of January and is trending downward, according to the report.
More articles on healthcare finance:
UMC approves debt repayment plan for bankrupt children’s hospital
UPMC gets financial boost from insurance division
AHA: Proposal to reduce Medicare appeals backlog won’t solve problem
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
